Walleye Capital’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Walleye Capital’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,182	Closed	-$113K	–	3838
2022 Q3	$113K	Buy	+20,182	New	+$126K	﹤0.01%	2376
2022 Q1	–	Sell	-14,767	Closed	-$270K	–	2777
2021 Q4	$270K	Sell	14,767 -10,973	-43%	-$139K	0.01%	1311
2021 Q3	$305	Buy	+25,740	New	+$375K	0.01%	1001
2020 Q4	–	Sell	-11,410	Closed	-$241K	–	1169
2020 Q3	$241K	Buy	+11,410	New	+$267K	0.03%	560

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Walleye Capital's OYST Position: Q4 2022 in Review

Walleye Capital sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 20,182 shares — an estimated $113K sold.

Walleye Capital first reported a position in OYST in Q3 2020 and held it in 4 quarters. The position peaked at $270K in Q4 2021. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

Walleye Capital reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 20,182 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $113K.
Walleye Capital first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Walleye Capital's Oyster Point Pharma, Inc. Common Stock position peaked at $270K in Q4 2021.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.